tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Paul Jeng, 7 are a BUY (100%).
Analyst Paul Jeng, currently employed at GUGGENHEIM,
Paul Jeng’s has documented 14 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IDYA, Ideaya Biosciences at 14-Apr-2026.
Analyst best performing recommendations are on ADAG (ADAGENE).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Nov-2025
$10
$5.81 (138.66%)
$9
Buy Since 18-Sep-2025
$9
$5.23 (138.73%)
Buy Since 07-Dec-2022
$7
$2.81 (67.06%)
$8
Buy Since 06-Aug-2025
$7
$2.81 (67.06%)
Buy Since 08-Mar-2021
$3.5
$-0.69 (-16.47%)
$33
Which stock is Paul Jeng is most bullish on?
Which stock is Paul Jeng is most reserved on?
What Year was the first public recommendation made by Paul Jeng?
